• Cardiology, Diabetes & Nephrology
    • Cardiology, Diabetes & Nephrology – London
    • Cardiology, Diabetes & Nephrology – Brazil
    • Cardiology, Diabetes & Nephrology – Canada
    • Cardiology, Diabetes & Nephrology – USA
    • Hatter Horizon Series
    • The 18th Malvern Diabetic Foot Conference
    • Previous Events
      • CDNATL 2019 – London
      • CDNATL 2019 – Brazil
      • CDNATL 2018
      • CDNATL 2017
      • CDNATL 2016
      • CDNATL 2015
      • CDNATL 2014
      • CDATL 2013
      • CDATL 2012
      • NATL 2012
      • CDATL 2011
      • CDATL 2010
      • NATL 2010
      • CATL 2009
      • NATL 2009
  • Cell Therapy
    • Cell Therapy at the Limits 2021
  • Oncology
    • Previous Events
      • Accelerating Cancer Immunotherapy 2017
      • OATL 2016
      • OATL 2015
      • OATL 2014
      • OATL 2012
      • OATL 2011
      • OATL 2010
      • UCL Frontiers of Oncology 2019
        • Haematology
        • Melanoma
        • Urology
        • Women’s Health
        • Lung Cancer
        • Gastrointestinal Oncology
        • Paediatric Oncology
        • Supporters
  • Multiple Sclerosis
    • Multiple Sclerosis at the Limits 2021
    • Multiple Sclerosis Nurses at the Limits 2021
    • Previous Events
      • Multiple Sclerosis Nurses at the Limits 2020
      • Multiple Sclerosis Nurses at the Limits 2019
      • MSATL 2018: Introduction
      • MSATL 2017: Introduction
  • About
    • Academic Founders
    • Independence
    • The Lancet
    • Support & Sponsorship
    • Delegate Invitations
  • Supporters
  • Archive
    • CDNATL 2019 – London
    • CDNATL 2019 – Brazil
    • Multiple Sclerosis at the Limits 2018
    • Multiple Sclerosis at the Limits 2020
    • Multiple Sclerosis Nurses at the Limits 2020
    • Multiple Sclerosis Nurses at the Limits 2019
    • Hatter Horizon Series
      • Horizon GP Programme 2019
      • Hatter Horizon Series 2019
      • Hatter Horizon Series 2018
      • Hatter Horizon Series 2017
    • Cardiology, Diabetes & Nephrology at the Limits 2018
    • Accelerating Cancer Immunotherapy 2017
    • Oncology at the Limits 2017

Tuesday 6th & Wednesday 7th November 2018
The Royal College of Physicians, London, UK

 


Chairs

Gavin Giovannoni
Professor Gavin Giovannoni
Chair of Neurology,
Barts and The London School
of Medicine and Dentistry,
London, UK
Professor William CarrollProfessor William Carroll
Clinical Professor of Neurology,
University of Western Australia;
Consultant neurologist at the Perron Institute,
Perth, Australia

Tuesday 6th November
08:30
Badge Collection & Coffee
09:30
Introduction & welcome from the Chairs
09:40
Session 1: Co-morbidities
The role of comorbidities in multiple sclerosis
Dr Ruth Ann Marrie
Departments of Internal Medicine and Community Health Sciences, Max Rady College of Medicine, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, Canada
10:20
The potential role of statins in treatment of multiple sclerosis
Professor John Greenwood
Hugh Davson Professor of Biomedical Research and Head of the Department of Cell Biology, Institute of Ophthalmology, University College London, UK
11:00
Coffee Break
11:25
Smoking and multiple sclerosis
Dr Anna Hedström
Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden
12:05
Exercise intervention in the management of MS
Professor Rob Motl
Professor and Director of Research, Department of Physical Therapy; Associate Director of Research, UAB|Lakeshore Collaborative; Associate Director, UAB Center for Exercise Medicine; Director, REACT Mobile Technology Laboratory; Co-Director, Exercise Neuroscience Research Laboratory, The University of Alabama at Birmingham, AL USA
12:45
Lunch
13:45
Session 2: Cellular therapies in the treatment of Multiple Sclerosis
Haemopoietic stem cell transplantation in the management of multiple sclerosis
Professor Richard K. Burt
Chief of Immunotherapy and Autoimmune Diseases & Professor of Medicine, Division of Immunotherapy, Northwestern University Feinberg School of Medicine, Chicago, IL, USA
14:25
Mesenchymal stem cell transplantation in MS
Professor Dimitrios Karussis
Director of the Hadassah Unit of Neuroimmunology and cell therapies, Department of Neurology and Agnes-Ginges Centre for Neurogenetics, Hadassah-Hebrew University Medical Organisation, Jerusalem, Israel
15:05
Coffee Break
15:30
Are current patient expectations of cellular treatments realistic?
Professor Gianvito Martino
Scientific Director, San Raffaele Scientific Institute; Professor of Experimental Biology, Vita Salute San Raffaele University, Milan, Italy
16:10
Is B-cell depletion sufficient as a treatment strategy in MS?
Professor Fredrik Piehl
Professor of Clinical Neuroscience, Department of Clinical Neuroscience, The Karolinska Institutet, Stockholm, Sweden
16:50
Debate: 'Neurologists should offer patients radiologically isolated syndrome disease-modifying therapies'
For
Professor Gavin Giovannoni
Barts and The London School of Medicine and Dentistry, London, UK
Against
Dr David Cottrell
Senior Clinical Lecturer in Neurology, University of Bristol, UK
17:50
Close
19:00
Conference Dinner (The Royal College of Physicians)
Wednesday 7th November
09:30
Session 3: De-risking multiple sclerosis treatments in clinical practice
Derisking lymphopenia in the management of MS
Professor Alasdair Coles
Professor of Neuroimmunology, Department of Clinical Neurosciences (A.J.C., D.A.S.C.), University of Cambridge, UK
10:10
Managing pharmacovigilance burden in MS
Associate Professor Stephen Reddel
Staff Specialist Neurologist, Concord Repatriation & General Hospital Sydney; Consultant Neurologist The Brain & Mind Centre, University of Sydney, Australia
10:50
Coffee Break
11:15
PML and multiple sclerosis
Professor David Clifford
Professor of Neurology and Medicine & Melba and Forest Seay Professor of Clinical Neuropharmacology in Neurology, Department of Neurology, Washington University School of Medicine, St. Louis, MO, USA
11:55
A practical guide to treatment cessation
Dr Robert Bermel
Staff Neurologist and Director, Mellen Center for Multiple Sclerosis; Neurological Institute, Cleveland Clinic
12:35
Lunch
13:30
Session 4: Progressive multiple sclerosis & hand function
Hand function as an outcome measure in clinical trials
Professor Dr Bernard Uitdehaag
Professor of Neurology, Chair of the Department of Neurology, Director of the MS Center Amsterdam, VU University Medical Center, Amsterdam, The Netherlands
14:10
Designing disease modifying therapy trials in more advanced disease
Professor Gary Cutter
Professor of Biostatistics, University of Alabama at Birmingham, School of Public Health, Department of Biostatistics, Birmingham, AL, USA
14:50
Coffee Break
15:15
Using MRI as an outcome measure in progressive MS
Dr Arman Eshaghi
Research Associate, Neuroinflammation, UCL Queen Square Institute of Neurology, London, UK
15:55
The identification of potential treatment targets in advancing MS
Professor Bruno Stankoff
Professor of Neurology at Pierre and Marie Curie University, Paris, France
16:35
Close

Cardiology, Diabetes & Nephrology at the Limits Canada
Wednesday, 3 & Thursday, 4 March 2021, Virtual Meeting

Cardiology, Diabetes & Nephrology at the Limits 2021
Monday, 12 - Tuesday, 13 April 2021, London, UK

The 18th Malvern Diabetic Foot Conference
Wednesday, 12 – Friday, 14 May 2021, Malvern, UK

Hatter Horizon GP Meeting
Wednesday, 19 May 2021
London, UK

Hatter Horizon Series
Friday, 21 May 2021
London, UK

Multiple Sclerosis Nurses
at the Limits

Friday, 4 & Saturday, 5 June 2021, London, UK

Multiple Sclerosis at the Limits
Thursday, 24 & Friday, 25 June 2021, London, UK

Cardiology, Diabetes & Nephrology at the Limits Brazil
Friday, 16 - Saturday, 17 July 2021, São Paulo, Brazil

Cell Therapy at the Limits 2021
Wednesday, 21 & Thursday, 22 July 2021, London, UK

Policy links

  • Medical Disclaimer
  • Disclosure
  • E-mail Policy
  • Privacy Policy
  • Anti-spam Policy
  • Disclaimer
  • External Links Policy
  • Terms of use
  • Contact
  • The Lancet
  • UCL
  • UCT
  • Brigham & Women’s Hospital
  • The University of Campinas
© 2020 At the Limits Ltd.
This site uses cookies More info